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Virus with an unusual ability to adapt to
new vertebrate host species.
Negative-sense RNA genome, 12–
14 kb, in eight (IAV, IBV) or seven (ICV,
IDV) segments.
IAV, IBV, and ICV are highly
transmissible human respiratory
pathogens.
Global distribution. In temperate
climates, peaks in winter months.
Adaptation of new IAV strains to
humans causes pandemics.
Diverse IAV strains circulate in
waterfowl, often as asymptomatic
gastrointestinal infections.
DISEASE FACTS:
An acute infection. In humans, viral
shedding begins after around 1 day
and peaks before the onset of
symptoms.
Typical symptoms include sudden
onset of fever, muscle pain, headachesRNP NP Polymerase
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Key:
This infographic brieﬂy summarises the natural history, replication cycle, and pathogenesis of inﬂuenza viruses,
the cause of seasonal inﬂuenza and of inﬂuenza pandemics. and exhaustion, peaking 2–3 days after
infection and resolving within 1–2
weeks.
Serious illness occurs in a minority of
cases, often due to secondary bacterial
infections or exacerbation of
cardiovascular and respiratory illness.
At-risk groups include infants, older
adults, pregnant women, and the
immunocompromised.
The large total number of cases meansInﬂuenza viruses infect many vertebrates, with Inﬂuenza A, B and C viruses (IAV, IBV, and ICV) infecting humans.
High mutation rates allow the evasion of immunity. IAV from different host species can ‘reassort’ their segmented
genomes, producing pandemic strains that are antigenically novel but otherwise well adapted to humans.
The ‘Great Inﬂuenza’ pandemic of 1918 remains the worst outbreak of infectious disease in history. There is
concern that highly pathogenic avian inﬂuenza viruses of the H5 and H7 subtypes may evolve to cause similar
pandemics.
In humans, inﬂuenza viruses infect the respiratory epithelium. The haemagglutinin (HA) proteins of IAV and IBV, or
the haemagglutinin-esterase-fusion (HEF) proteins of ICV, bind sialic acid, causing endocytosis. Unusually
among RNA viruses, the viral genome replicates in the nucleus. New viruses assemble at the cell surface and are
released by the receptor-cleaving neuraminidase (NA) proteins of IAV and IBV or the ICV HEF protein.that seasonal inﬂuenza, mainly caused
by IAV and IBV, typically kills 290 000–
650 000 a year globally.
IAV pandemics can be more serious.
The ‘Great Inﬂuenza’ of 1918 killed
around 1 in 30 of the global population
in 18 months.
IAV also causes serious illness in
poultry.
Seasonal inﬂuenza vaccines are
available but must be regularly
updated.
NA inhibitors can be used for
treatment.
*Correspondence:H1N1 H1N1 H1N1H2N2
H3N2
1918 1957 1977 2009
1968
Reassortment
“anƟgenic shiŌ”
MutaƟons
“anƟgenic driŌ”
Weaker immunity:
seasonal epidemics
No immunity:
pandemics
ExisƟng immunity:
IAV pandemics
introduce new
seasonal strainsTrends in Microbiology, Month TAXONOMY AND CLASSIFICATION:
ORDER: Unassigned
FAMILY: Orthomyxoviridae
GENERA (SPECIES): Alphainﬂuenzavirus (Inﬂuenza A virus),
Betainﬂuenzavirus (Inﬂuenza B virus), Gammainﬂuenzavirus
(Inﬂuenza C virus) and Deltainﬂuenzavirus (Inﬂuenza D virus)
can all infect mammals. Distinct inﬂuenza viruses of ﬁsh
and amphibians have been reported
SUBTYPES AND LINEAGES: based on the major surface
antigens, there are 18 HA (H1–H18) and 11 NA (N1–N11)
subtypes of Inﬂuenza A virus and two recent lineages,
‘Victoria’ and ‘Yamagata,’ of Inﬂuenza B virus
GENOME: segmented, negative-sense RNA
STRUCTURE: enveloped, pleomorphic (ranging from
spheres to extremely long ﬁlaments) with a helical capsidedward.hutchinson@glasgow.ac.uk
(E.C. Hutchinson).Year, Vol. xx, No. yy © 2018 The Author. Published by Elsevier Ltd. This
is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1016/j.tim.2018.05.013 1
Trends in Microbiology | Microbe of the Month
Acknowledgments
E.C.H. is funded by an MRC Career Development Award (MR/N008618/1).
Literature
1. Carrat, F. et al. (2008) Time lines of infection and disease in human inﬂuenza: a review of volunteer challenge studies. Am. J. Epidemiol. 167, 775–785
2. Iuliano, A.D. et al. (2018) Estimates of global seasonal inﬂuenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300
3. Hirve, S. et al. (2016) Inﬂuenza seasonality in the tropics and subtropics – when to vaccinate? PLoS One 11, e0153003
4. Shi, M. et al. (2018) The evolutionary history of vertebrate RNA viruses. Nature 556, 197–202
5. Taubenberger, J.K. and Morens, D.M. (2006) 1918 Inﬂuenza: the mother of all pandemics. Emerg. Infect. Dis. 12, 15–22
6. Webster, R.G. et al. (1992) Evolution and ecology of inﬂuenza A viruses. Microbiol. Rev. 56, 152–179
7. Krammer, F. and Palese, P. (2015) Advances in the development of inﬂuenza virus vaccines. Nat. Rev. Drug Discov. 14, 167–182
8. Farrukee, R. and Hurt, A.C. (2017) Antiviral drugs for the treatment and prevention of inﬂuenza. Curr. Treatm. Options Infect. Dis. 9, 318–332
9. Eisfeld, A.J. et al. (2015) At the centre: inﬂuenza A virus ribonucleoproteins. Nat. Rev. Microbiol. 13, 28–412 Trends in Microbiology, Month Year, Vol. xx, No. yy © 2018 The Author. Published by Elsevier Ltd. This
is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
https://doi.org/10.1016/j.tim.2018.05.013
